F. Tas Et Al. , "Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.," American journal of clinical oncology , vol.24, no.6, pp.547-50, 2001
Tas, F. Et Al. 2001. Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.. American journal of clinical oncology , vol.24, no.6 , 547-50.
Tas, F., Aykan, F., Alici, S., Kaytan, E., Aydiner, A., & Topuz, E., (2001). Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.. American journal of clinical oncology , vol.24, no.6, 547-50.
Tas, Faruk Et Al. "Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.," American journal of clinical oncology , vol.24, no.6, 547-50, 2001
Tas, Faruk Et Al. "Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.." American journal of clinical oncology , vol.24, no.6, pp.547-50, 2001
Tas, F. Et Al. (2001) . "Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.." American journal of clinical oncology , vol.24, no.6, pp.547-50.
@article{article, author={Faruk TAŞ Et Al. }, title={Prognostic factors in pancreatic carcinoma: serum LDH levels predict survival in metastatic disease.}, journal={American journal of clinical oncology}, year=2001, pages={547-50} }